CorMedix reports positive Phase III trial results for REZZAYO fungal prophylaxis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. FDX
5. IBM
6. META
7. MU
8. ACN
9. USO
10. NVDA

Go back to CorMedix reports positive Phase III trial results for REZZAYO fungal prophylaxis
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 8.60 -0.22 (2.49%)
Previous Close $8.82    52 Week High $4.54 
Open $8.75    52 Week Low $1.15 
Day High $8.96    P/E N/A 
Day Low $8.60    EPS $-0.55 
Volume 1,271,167